Literature DB >> 25543329

Breast Cancer: Epidemiology and Etiology.

ZiQi Tao1, Aimin Shi2, Cuntao Lu3, Tao Song4, Zhengguo Zhang5, Jing Zhao6.   

Abstract

Breast cancer, the most frequently occurring cancer in women, is a major public health problem, with 1,384,155 estimated new cases worldwide with nearly 459,000 related deaths. Breast cancer is highly heterogeneous in its pathological characteristics, some cases showing slow growth with excellent prognosis, while others being aggressive tumors. Current predictions and statistics suggest that both worldwide incidence of breast cancer and related mortality are on the rise. According to 2012 GLOBOCAN statistics, nearly 1.7 million women were diagnosed with breast cancer with 522,000 related deaths-an increase in breast cancer incidence and related mortality by nearly 18 % from 2008. According to American Cancer Society, one in eight women in the United States will develop breast cancer in her lifetime. It has been predicted that the worldwide incidence of female breast cancer will reach approximately 3.2 million new cases per year by 2050. These numbers reflect the magnitude of breast cancer incidence, its effect on society worldwide and the need for urgency for preventive and treatment measures. While technological advances in medical sciences and health care have made it possible to detect the disease early and to start the treatment early on to prevent the progress of the disease into a metastatic state, there are several unanswered questions with regard to the molecular mechanisms that underlie the aggressiveness of certain forms of this disease. Epidemiological studies suggest that addressing socio economical issues is utmost important, so that all women have equal access to medical care from screening to advanced treatment, and only such decisive action can help reduce the worldwide burden of breast cancer.

Entities:  

Keywords:  Breast cancer; Epidemiology; Etiology

Mesh:

Year:  2015        PMID: 25543329     DOI: 10.1007/s12013-014-0459-6

Source DB:  PubMed          Journal:  Cell Biochem Biophys        ISSN: 1085-9195            Impact factor:   2.194


  164 in total

1.  Fragment-based in silico modeling of multi-target inhibitors against breast cancer-related proteins.

Authors:  Alejandro Speck-Planche; M Natália D S Cordeiro
Journal:  Mol Divers       Date:  2017-02-13       Impact factor: 2.943

Review 2.  Healthcare system distrust and the breast cancer continuum of care.

Authors:  Morgane C Mouslim; Renee M Johnson; Lorraine T Dean
Journal:  Breast Cancer Res Treat       Date:  2020-01-25       Impact factor: 4.872

Review 3.  Patient reported outcome measures (PROMs) following mastectomy with breast reconstruction or without reconstruction: a systematic review.

Authors:  Leonardo Z Cordova; David J Hunter-Smith; Warren M Rozen
Journal:  Gland Surg       Date:  2019-08

4.  BRCA population screening for predicting breast cancer: for or against?

Authors:  Giuseppe Lippi; Camilla Mattiuzzi; Martina Montagnana
Journal:  Ann Transl Med       Date:  2017-07

5.  ERINA Is an Estrogen-Responsive LncRNA That Drives Breast Cancer through the E2F1/RB1 Pathway.

Authors:  Zihui Fang; Yue Wang; Zehua Wang; Meishu Xu; Songrong Ren; Da Yang; Mei Hong; Wen Xie
Journal:  Cancer Res       Date:  2020-08-21       Impact factor: 12.701

Review 6.  State of the evidence 2017: an update on the connection between breast cancer and the environment.

Authors:  Janet M Gray; Sharima Rasanayagam; Connie Engel; Jeanne Rizzo
Journal:  Environ Health       Date:  2017-09-02       Impact factor: 5.984

7.  ELLPMDA: Ensemble learning and link prediction for miRNA-disease association prediction.

Authors:  Xing Chen; Zhihan Zhou; Yan Zhao
Journal:  RNA Biol       Date:  2018-05-25       Impact factor: 4.652

8.  Immunosuppression of breast cancer cells mediated by transforming growth factor-β in exosomes from cancer cells.

Authors:  Lei Rong; Rong Li; Shaoying Li; Rongcheng Luo
Journal:  Oncol Lett       Date:  2015-10-29       Impact factor: 2.967

9.  Drug Screening of Potential Multiple Target Inhibitors for Estrogen Receptor-α-positive Breast Cancer.

Authors:  Juan-Cheng Yang; Yang-Chang Wu; Yun-Hao Dai; Guan-Yu Chen; Chih-Hsin Tang; Wei-Chien Huang
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

10.  Multiple spider telangiectasias in a breast cancer patient on T-DM1 treatment.

Authors:  Juncal Ruiz-Rivero; Celia Horcajada-Reales; Juan C Tardío; Jesús Manuel Borbujo-Martínez
Journal:  An Bras Dermatol       Date:  2018 Nov/Dec       Impact factor: 1.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.